<DOC>
	<DOCNO>NCT01066156</DOCNO>
	<brief_summary>This 8 week study investigate therapeutic response Seroquel pharmacotherapy PTSD .</brief_summary>
	<brief_title>Post-Traumatic Stress Disorder ( PTSD ) Seroquel</brief_title>
	<detailed_description>An initial telephone interview conduct determine potential subject meet basic study requirement . If obvious counterindications present , subject schedule screen visit . After brief subject reason research , give opportunity read Informed Consent Form , approve Cambridge Health Alliance Institutional ReviewBoard , ask question prior sign . Subjects give copy sign Consent Form . Each subject complete standardize interview schedule design obtain personal background data along psychodiagnostic psychometric evaluation . An open-label treatment utilized patient . Seroquel tablets flexibly dose begin target dose 25 mg per day take 8 week period .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision write informed consent Fluency English A diagnosis PTSD No pregnancy Righthandedness Pregnancy lactation Any cognitive impairment precludes informed consent Known intolerance lack response Seroquel Previous enrollment randomization treatment present study Participation another drug trial within 4 week prior enrollment study Patients Diabetes Mellitus History allergic reaction hypersensitivity Seroquel Contraindications magnetic resonance image Treatment effective medication PTSD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Post-traumatic Stress Disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>Seroquel</keyword>
	<keyword>fMRI</keyword>
</DOC>